Notice: This company has been marked as potentially delisted and may not be actively trading. Deep Medicine Acquisition (DMAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends DMAQ vs. RIME, TRUG, SRM, IMTE, AQB, SPGC, BBIG, YMAT, SONY, and GOLFShould you be buying Deep Medicine Acquisition stock or one of its competitors? The main competitors of Deep Medicine Acquisition include Algorhythm (RIME), TruGolf (TRUG), SRM Entertainment (SRM), Integrated Media Technology (IMTE), AquaBounty Technologies (AQB), Sacks Parente Golf (SPGC), Vinco Ventures (BBIG), J-Star (YMAT), Sony Group (SONY), and Acushnet (GOLF). These companies are all part of the "recreation" industry. Deep Medicine Acquisition vs. Algorhythm TruGolf SRM Entertainment Integrated Media Technology AquaBounty Technologies Sacks Parente Golf Vinco Ventures J-Star Sony Group Acushnet Algorhythm (NASDAQ:RIME) and Deep Medicine Acquisition (NASDAQ:DMAQ) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Do insiders & institutionals hold more shares of RIME or DMAQ? 18.4% of Deep Medicine Acquisition shares are held by institutional investors. 9.4% of Algorhythm shares are held by insiders. Comparatively, 1.7% of Deep Medicine Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to RIME or DMAQ? In the previous week, Algorhythm had 1 more articles in the media than Deep Medicine Acquisition. MarketBeat recorded 1 mentions for Algorhythm and 0 mentions for Deep Medicine Acquisition. Algorhythm's average media sentiment score of 1.89 beat Deep Medicine Acquisition's score of 0.00 indicating that Algorhythm is being referred to more favorably in the media. Company Overall Sentiment Algorhythm Very Positive Deep Medicine Acquisition Neutral Is RIME or DMAQ more profitable? Deep Medicine Acquisition's return on equity of 0.00% beat Algorhythm's return on equity.Company Net Margins Return on Equity Return on Assets AlgorhythmN/A -198.73% -36.64% Deep Medicine Acquisition N/A N/A N/A Which has more volatility and risk, RIME or DMAQ? Algorhythm has a beta of 0.17, suggesting that its share price is 83% less volatile than the S&P 500. Comparatively, Deep Medicine Acquisition has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500. Which has preferable earnings & valuation, RIME or DMAQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlgorhythm$29.05M0.17N/AN/AN/ADeep Medicine AcquisitionN/AN/AN/AN/AN/A Does the MarketBeat Community believe in RIME or DMAQ? Algorhythm and Deep Medicine Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlgorhythmN/AN/ADeep Medicine AcquisitionN/AN/A SummaryAlgorhythm beats Deep Medicine Acquisition on 5 of the 8 factors compared between the two stocks. Remove Ads Get Deep Medicine Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAQ vs. The Competition Export to ExcelMetricDeep Medicine AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$1.63M$457.00M$127.72M$8.08BDividend YieldN/A7.18%N/A4.04%P/E RatioN/A2.151.2119.00Price / SalesN/A64.4018.42120.61Price / CashN/A69.0193.7934.64Price / BookN/A3.700.914.26Net IncomeN/A$35.78M$1.63M$247.00M Deep Medicine Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAQDeep Medicine AcquisitionN/A$0.37-3.4%N/A-73.2%$1.63MN/A0.0093Gap DownHigh Trading VolumeRIMEAlgorhythmN/A$2.12+8.7%N/AN/A$5.05M$29.05M0.0027Gap DownTRUGTruGolf2.3578 of 5 stars$0.38+1.5%$2.00+426.0%-74.3%$4.52M$20.35M-0.9193Short Interest ↑Gap DownSRMSRM Entertainment0.282 of 5 stars$0.40-3.0%N/A-64.9%$4.14M$4.59M-0.97N/AShort Interest ↑Gap DownIMTEIntegrated Media TechnologyN/A$1.13+2.7%N/A-58.2%$3.88M$113,200.000.0010Positive NewsAQBAquaBounty Technologies0.8756 of 5 stars$0.66-2.8%N/A-71.8%$2.55M$1.26M-0.03100Short Interest ↓Gap DownSPGCSacks Parente Golf0.8892 of 5 stars$0.18+15.0%N/A-98.3%$320,000.00$2.49M-0.0518Upcoming EarningsStock SplitShort Interest ↑News CoveragePositive NewsGap DownHigh Trading VolumeBBIGVinco VenturesN/A$0.00-42.1%N/A-80.0%$14,000.00$31.78M0.0050Gap DownYMATJ-StarN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeSONYSony Group2.9196 of 5 stars$24.33+0.6%$28.00+15.1%+561.2%$147.11B$13.81T19.74113,000Options VolumePositive NewsGap UpGOLFAcushnet3.3807 of 5 stars$66.21+2.1%$72.80+10.0%+8.6%$3.97B$2.46B22.527,300Insider TradePositive News Remove Ads Related Companies and Tools Related Companies Algorhythm Alternatives TruGolf Alternatives SRM Entertainment Alternatives Integrated Media Technology Alternatives AquaBounty Technologies Alternatives Sacks Parente Golf Alternatives Vinco Ventures Alternatives J-Star Alternatives Sony Group Alternatives Acushnet Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAQ) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump announces revenge on BidenA former CIA insider just made a stunning prediction: Trump’s revenge on Biden will end America’s energy cr...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deep Medicine Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Deep Medicine Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAQ Stock Alerts